Rivaroxaban (BAY 59-7939) | Factor Xa Inhibitor | MedChemExpress
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin | Cardiovascular Diabetology | Full Text
Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetes - ScienceDirect
VOYAGER PAD: Rivaroxaban in PAD with & without Comorbid Diabetes
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink
Rivaroxaban efficace anche nei pazienti con diabete - CardioInfo
Managing thrombotic risk in patients with diabetes | Cardiovascular Diabetology | Full Text
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism
Managing thrombotic risk in patients with diabetes | Cardiovascular Diabetology | Full Text
Rivaroxaban – Wikipedia
Selection criteria. Application of the selection criteria yielded more... | Download Scientific Diagram
Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus - Li - 2018 - Diabetic Medicine - Wiley Online Library
JCM | Free Full-Text | A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index
Thesis | Effectiveness and safety of apixaban versus rivaroxaban in patients with nonvalvular atrial fibrillation and type 2 diabetes mellitus | ID: ks65hj13f | eScholarship@McGill
Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model | Scientific Reports
Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD | tctmd.com
Rivaroxaban (Xarelto): uses, dose and side effects
JCM | Free Full-Text | A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index
NEUE INDIKATIONEN FÜR FAKTOR-XA-HEMMSTOFF RIVAROXABAN (XARELTO)
The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis | SpringerLink